Drug Interaction Report

Larotrectinib and Colchicine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Larotrectinib

No brand names on record
+

Colchicine

Colcrys Colcrys® Gloperba Gloperba® Lodoco Mitigare
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 42 documented Larotrectinib interactions, 38 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Larotrectinib can raise colchicine levels and the risk of serious colchicine toxicity, so this combination is best avoided; if both are needed, your team will lower the colchicine dose or frequency and watch you closely. Talk to your pharmacist or doctor before making any changes.

Let's talk about taking larotrectinib (a cancer medicine) together with colchicine (used for gout and some other conditions). Your body normally breaks down colchicine using an enzyme called CYP3A4. Larotrectinib can slow that enzyme down, which means colchicine can build up higher than it should in your body.

When colchicine builds up, it can cause serious problems like bad diarrhea, muscle weakness, and other toxic effects. The good news is your care team can manage this. Please don't stop or change either medicine on your own. Just check in with your pharmacist or doctor so they can adjust things and keep an eye on you.

Effect: Larotrectinib (a CYP3A4 inhibitor) may reduce CYP3A4-mediated metabolism of colchicine, increasing colchicine exposure and risk of dose-dependent toxicity.

  • Direction: Increased colchicine effect/toxicity (neither drug is a prodrug here).
  • Mechanism: Inhibition of CYP3A4 (colchicine is also a P-gp substrate).
  • Evidence: Theoretical; onset unspecified. Severity rated major.
  • Management: Avoid concomitant use given potential for serious/life-threatening toxicity. If necessary, reduce colchicine daily dose or frequency and monitor closely for toxicity (GI symptoms, myopathy, myelosuppression). Greater caution in hepatic or renal impairment.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased colchicine exposure and an increased risk of colchicine-related toxicity

Interaction Deep Dive

Because of the risk of serious, potentially fatal toxicity, colchicine should not be taken together with CYP3A4 inhibitors. When combined therapy with colchicine and a CYP3A4 inhibitor cannot be avoided, modify the colchicine dose (either by lowering the total daily amount or by decreasing how often it is given) while closely watching for signs of colchicine toxicity1.

Why it happens (mechanism)

Inhibition of CYP3A4-mediated metabolism of colchicine

How to manage this interaction

Here is how a care team typically handles this combination:

  • Avoid together when possible because of the potential for serious toxicity.
  • If both are truly needed, your team may lower the colchicine dose or take it less often and monitor you more closely for side effects.
  • Watch for warning signs like ongoing diarrhea, vomiting, muscle pain or weakness, numbness, or unusual tiredness, and report them right away.

What you should do: Keep taking both exactly as prescribed until you speak with your pharmacist or prescriber. Do not adjust doses on your own, but do bring this interaction to their attention so they can tailor your plan.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Larotrectinib and Colchicine together?

Larotrectinib can raise colchicine levels and the risk of serious colchicine toxicity, so this combination is best avoided; if both are needed, your team will lower the colchicine dose or frequency and watch you closely. Talk to your pharmacist or doctor before making any changes. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Larotrectinib and Colchicine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Larotrectinib and Colchicine interaction managed?

Here is how a care team typically handles this combination: Avoid together when possible because of the potential for serious toxicity. If both are truly needed, your team may lower the colchicine dose or take it less often and monitor you more closely for side effects. Watch for warning signs like ongoing diarrhea, vomiting, muscle pain or weakness, numbness, or unusual tiredness, and report them… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Larotrectinib or Colchicine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: MITIGARE(R) oral capsules, colchicine oral capsules. Hikma Specialty USA Inc (per FDA), Columbus, OH, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.